BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 9461144)

  • 1. Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease.
    Kubota E; Kubota T; Matsumoto J; Shibata T; Murakami KI
    J Oral Maxillofac Surg; 1998 Feb; 56(2):192-8. PubMed ID: 9461144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 1 beta and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint.
    Kubota E; Imamura H; Kubota T; Shibata T; Murakami K
    J Oral Maxillofac Surg; 1997 Jan; 55(1):20-7; discussion 27-8. PubMed ID: 8994464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of matrix metalloproteinases (MMPs) in synovial fluid from patients with temporomandibular disorder.
    Kubota T; Kubota E; Matsumoto A; Kawai Y; Saito H; Mikuni-Takagaki Y; Sato S
    Eur J Oral Sci; 1998 Dec; 106(6):992-8. PubMed ID: 9879910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does joint effusion on T2 magnetic resonance images reflect synovitis? Part 2. Comparison of concentration levels of proinflammatory cytokines and total protein in synovial fluid of the temporomandibular joint with internal derangements and osteoarthrosis.
    Segami N; Miyamaru M; Nishimura M; Suzuki T; Kaneyama K; Murakami K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Oct; 94(4):515-21. PubMed ID: 12374930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of interleukin-1 receptor antagonist, interleukin-10, and transforming growth factor-beta1 in synovial fluid aspirates of patients with temporomandibular disorders.
    Fang PK; Ma XC; Ma DL; Fu KY
    J Oral Maxillofac Surg; 1999 Aug; 57(8):922-8; discussion 928-9. PubMed ID: 10437719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The increase of parathyroid hormone-related peptide and cytokine levels in synovial fluid of elderly rheumatoid arthritis and osteoarthritis.
    Horiuchi T; Yoshida T; Koshihara Y; Sakamoto H; Kanai H; Yamamoto S; Ito H
    Endocr J; 1999 Oct; 46(5):643-9. PubMed ID: 10670749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases in mild and severe temporomandibular joint internal derangement synovial fluid.
    Srinivas R; Sorsa T; Tjäderhane L; Niemi E; Raustia A; Pernu H; Teronen O; Salo T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):517-25. PubMed ID: 11346728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
    J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosaminoglycan components in temporomandibular joint synovial fluid as markers of joint pathology.
    Shibata T; Murakami KI; Kubota E; Maeda H
    J Oral Maxillofac Surg; 1998 Feb; 56(2):209-13. PubMed ID: 9461147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of synovial fluid markers of catabolism and anabolism in osteoarthritis, rheumatoid arthritis and asymptomatic organ donors.
    Kokebie R; Aggarwal R; Lidder S; Hakimiyan AA; Rueger DC; Block JA; Chubinskaya S
    Arthritis Res Ther; 2011 Mar; 13(2):R50. PubMed ID: 21435227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the cytokine profiles of the synovial fluid in a normal temporomandibular joint: preliminary study.
    Kim YK; Kim SG; Kim BS; Lee JY; Yun PY; Bae JH; Oh JS; Ahn JM; Kim JS; Lee SY
    J Craniomaxillofac Surg; 2012 Dec; 40(8):e337-41. PubMed ID: 22425498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 beta, interleukin-6, and tissue inhibitor of metalloproteinase-1 in the synovial fluid of the temporomandibular joint with respect to cartilage destruction.
    Shinoda C; Takaku S
    Oral Dis; 2000 Nov; 6(6):383-90. PubMed ID: 11355271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated synovial fluid levels of interleukin-6 and tumor necrosis factor associated with early experimental canine osteoarthritis.
    Venn G; Nietfeld JJ; Duits AJ; Brennan FM; Arner E; Covington M; Billingham ME; Hardingham TE
    Arthritis Rheum; 1993 Jun; 36(6):819-26. PubMed ID: 8507225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteoglycans in the synovial fluid of the temporomandibular joint as an indicator of changes in cartilage metabolism during primary and secondary osteoarthritis.
    Ratcliffe A; Israel HA; Saed-Nejad F; Diamond B
    J Oral Maxillofac Surg; 1998 Feb; 56(2):204-8. PubMed ID: 9461146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinases and aggrecanase in the synovial fluids of patients with symptomatic temporomandibular disorders.
    Yoshida K; Takatsuka S; Hatada E; Nakamura H; Tanaka A; Ueki K; Nakagawa K; Okada Y; Yamamoto E; Fukuda R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul; 102(1):22-7. PubMed ID: 16831668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders.
    Takahashi T; Kondoh T; Fukuda M; Yamazaki Y; Toyosaki T; Suzuki R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Feb; 85(2):135-41. PubMed ID: 9503445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of inflammatory cytokines with arthroscopic findings in patients with temporomandibular joint internal derangements.
    Sandler NA; Buckley MJ; Cillo JE; Braun TW
    J Oral Maxillofac Surg; 1998 May; 56(5):534-43; discussion 543-4. PubMed ID: 9590334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders.
    Kaneyama K; Segami N; Nishimura M; Suzuki T; Sato J
    Br J Oral Maxillofac Surg; 2002 Oct; 40(5):418-23. PubMed ID: 12379189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.
    Yoshihara Y; Nakamura H; Obata K; Yamada H; Hayakawa T; Fujikawa K; Okada Y
    Ann Rheum Dis; 2000 Jun; 59(6):455-61. PubMed ID: 10834863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of fibroblast growth factor 2 in synovial fluids in human patients with internal derangement of the temporomandibular joint.
    Sato J; Segami N; Kaneyama K; Konishi H; Yoshitake Y; Nishikawa K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Dec; 96(6):673-9. PubMed ID: 14676757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.